Levy V G, Pillet B, Hecht Y
Ann Med Interne (Paris). 1979;130(8-9):427-31.
Thirty patients with alcoholic cirrhosis, ascitic during 13.6 +/- 13 months (mean +/- S.D.) were cured of ascites and followed up during 2 to 9 years (4.3 +/- 2.7 years). Twenty six were compared with a same number of cirrhotics, matched for age and sex, who died during the year after the first admission. Many biological data show statistical difference. Nevertheless no valuable prognosis can be predicted in an individual case. The clinical improvement is associated with major, sometimes total biological recovery. Other complications of cirrhosis (gastro-intestinal bleeding, hepatoma) may occur (7 cases with 5 deaths) or alcoholic hepatitis if alcohol withdrawal is stopped (3 cases, 2 deaths). Some associated diseases look unexpectedly frequent: diabetes (4 cases), obesity (9), nodular lipomatosis (14 cases) whose frequency looks higher than that can be calculated for a similar group of healthy subjects.
30例酒精性肝硬化患者,腹水持续时间为13.6±13个月(均值±标准差),腹水治愈后随访2至9年(4.3±2.7年)。将其中26例与26例年龄和性别相匹配的肝硬化患者进行比较,后者在首次入院后一年内死亡。许多生物学数据显示出统计学差异。然而,无法在个体病例中预测有价值的预后。临床改善与主要的、有时是完全的生物学恢复相关。肝硬化的其他并发症(胃肠道出血、肝癌)可能发生(7例,5例死亡),或者如果停止戒酒,可能会发生酒精性肝炎(3例,2例死亡)。一些相关疾病的出现频率出人意料地高:糖尿病(4例)、肥胖(9例)、结节性脂肪瘤(14例),其频率似乎高于为一组相似健康受试者计算出的频率。